Taipei Medical University (TMU) and Wistron Medical Technology (WMT) have signed an Industry–Academia Collaboration MOU, focusing on three major aspects: R&D and innovation, talent cultivation, and long-term collaboration.

This collaboration seeks to integrate medicine and technology to benefit a broader patient population.

TMU President Mai-Szu Wu stated the integration of the information systems implemented among TMU affiliated hospitals this year focuses on achieving “information integration”. He added that generative AI has been introduced to realize data automation while improving the quality of medical staff’s work. Further adoption of additional smart medical equipment is being planned to transition to add cloud interoperability and comprehensive intelligence to medical services. The collaboration with Wistron Medical will prioritize talent cultivation, industry–academia collaboration, and clinical trials to jointly promote the application and development of smart medicine.

TMU Shuang Ho Hospital and Wistron Medical have collaborated on various projects related to BestShape VS—an independently developed and manufactured non-contact, radar-based AI medical device for sleep apnea detection. A series of sleep studies was carried out at Shuang Ho Hospital’s Sleep Center since 2019; as a result of this research, the Thoracic Medicine Department was able to implement radar monitoring in the negative pressure isolation ward for contactless medical care during the COVID-19 outbreak. Moreover, the Non-Contact Physiological Monitoring Respiratory Care Platform has been awarded the Symbol of National Quality (SNQ) certificate for multiple years. Looking ahead, the team hopes to further market the technology to the Southeast Asian healthcare sector, promoting deeper integration of smart medicine technology into everyday life.

Non-contact AI smart care systems represent a key trend for the future. The millimeter wave radar technology combined with AIoT and AI machine learning enables continuous monitoring and analysis of patients’ physiological parameters without affecting their daily activities. Through this function, clinicians can make accurate diagnoses, detect early signs of diseases such as sleep apnea and cardiovascular disease, and proactively formulate treatment strategies, shifting from reactive to proactive care.

TMU and WMT have united to explore smart medicine. In addition to integrating the application of smart medical devices, their joint research paper on sleep has been published in the Journal of Clinical Sleep Medicine (JCSM)—a renowned journal of the American Academy of Sleep Medicine. Additionally, specialty departments such as Cardiology, Pulmonary, and the Hemodialysis Center are conducting clinical trials of the rapid test kit for respiratory system diseases, which is projected to obtain Taiwan’s Class II Smart Medical Device Certificate as early as next year. Through an interdisciplinary program for technology and medical talent cultivation, medical students and medical personnel will gain more profound insight into the recent advancements and practical applications of smart medicine through regular corporate lectures, visits, and internship exchanges. This initiative strengthens industry–academia collaboration while achieving resource sharing and complementary advantages.